References
- Sun J, Liu X, Zhang Q, Hong Y, Song B, Teng X, et al. Papillary thyroid carcinoma treated with radiofrequency ablation in a patient with hypertrophic cardiomyopathy: a case report. Korean J Radiol 2016;17:558-561 https://doi.org/10.3348/kjr.2016.17.4.558
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133 https://doi.org/10.1089/thy.2015.0020
- Scott E, Learoyd D, Clifton-Bligh RJ. Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives. Future Oncol 2016 Jul 8 [Epub]. http://dx.doi.org/10.2217/fon-2016-0171.
- Ito Y, Oda H, Miyauchi A. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review]. Endocr J 2016;63:323-328 https://doi.org/10.1507/endocrj.EJ15-0637
- Kim BW, Yousman W, Wong WX, Cheng C, McAninch EA. Less is more: comparing the 2015 and 2009 American Thyroid Association guidelines for thyroid nodules and cancer. Thyroid 2016;26:759-764 https://doi.org/10.1089/thy.2016.0068
Cited by
- RE: Management of Low-Risk Papillary Thyroid Microcarcinoma vol.18, pp.2, 2017, https://doi.org/10.3348/kjr.2017.18.2.408